Tom's of Maine toothpaste made with bacteria-contaminated water, says FDA - goodmorningamerica.com
FDA reports that Tom's of Maine toothpaste was made with bacteria-contaminated water, indicating potential cGMP violations at the manufacturing facility.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Tom's of Maine and its parent company, as well as any contract manufacturers or suppliers involved in their production; also serves as a warning for all OTC drug and cosmetic manufacturers. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the provided text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA publicly disclosed that Tom's of Maine toothpaste was manufactured using water contaminated with bacteria, signaling a potential violation of current Good Manufacturing Practice (cGMP) regulations.
Who it affects
Tom's of Maine and its parent company, as well as any contract manufacturers or suppliers involved in their production; also serves as a warning for all OTC drug and cosmetic manufacturers.
What you must do
Manufacturers should review their water systems and cGMP compliance, and if they are Tom's of Maine, cooperate with FDA and initiate corrective actions.
Deadline
Not specified in the provided text.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal - foxbusiness.com
- The FDA let substandard factories ship these medications to the U.S. - michiganadvance.com
- Tom’s of Maine says it will remedy mold, bacteria problems found by FDA at Sanford plant - mainebiz.biz
- The FTC Challenges Companies’ Allegedly Improper Orange Book Patent Listings - skadden.com
- Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides - drugtopics.com